E-viri
PDF
Recenzirano
Odprti dostop
-
Attarbaschi, Andishe; Abla, Oussama; Arias Padilla, Laura; Beishuizen, Auke; Burke, G. A. Amos; Brugières, Laurence; Bruneau, Julie; Burkhardt, Birgit; d'Amore, Emanuele S. G.; Klapper, Wolfram; Kontny, Udo; Pillon, Marta; Taj, Mary; Turner, Suzanne D.; Uyttebroeck, Anne; Woessmann, Wilhelm; Mellgren, Karin
Pediatric blood & cancer, August 2020, Letnik: 67, Številka: 8Journal Article
Pediatric‐type follicular (PTFL), marginal zone (MZL), and peripheral T‐cell lymphoma (PTCL) account each for <2% of childhood non‐Hodgkin lymphoma. We present clinical and histopathological features of PTFL, MZL, and few subtypes of PTCL and provide treatment recommendations. For localized PTFL and MZL, watchful waiting after complete resection is the therapy of choice. For PTCL, therapy is subtype‐dependent and ranges from a block‐like anaplastic large cell lymphoma (ALCL)‐derived and, alternatively, leukemia‐derived therapy in PTCL not otherwise specified and subcutaneous panniculitis‐like T‐cell lymphoma to a block‐like mature B‐NHL‐derived or, preferentially, ALCL‐derived treatment followed by hematopoietic stem cell transplantation in first remission in hepatosplenic and angioimmunoblastic T‐cell lymphoma.
